Amniotic Aaquaporins (AQP) in Normal and Pathological Pregnancies: Interest in Polyhydramnios.


Journal

Reproductive sciences (Thousand Oaks, Calif.)
ISSN: 1933-7205
Titre abrégé: Reprod Sci
Pays: United States
ID NLM: 101291249

Informations de publication

Date de publication:
10 2021
Historique:
received: 21 12 2020
accepted: 18 06 2021
pubmed: 14 7 2021
medline: 5 3 2022
entrez: 13 7 2021
Statut: ppublish

Résumé

Polyhydramnios is a common feature diagnosed by ultrasound in the second half of pregnancy. Biochemical analysis of amniotic fluid can be useful when suspecting Bartter syndrome or digestive atresia but in most of cases, no etiology of polyhydramnios is found because of the complex regulation of amniotic fluid. Aquaporins (AQP) are transmembrane channel proteins contributing to water transfers. Some of them are expressed in fetal membranes and placenta. Their expression has been shown to be disrupted in some pathological conditions such as maternal diabetes, often associated with polyhydramnios. AQP-1, 3 and 8 levels in amniotic fluid were retrospectively measured in patients suffering from polyhydramnios (n=21) from 23 weeks of gestation (WG). They were compared to the levels observed in control subjects (n=96) and their relationship with maternal factors and neonatal issues was analyzed. AQP-1, 3, 8 levels were physiologically fluctuating, AQP-1 levels always being the lowest and AQP-3 the highest, with a significant decrease at the end of pregnancy. AQPs/AFP ratios increased about 8 folds during pregnancy, their kinetic profiles reflecting physiological dynamic evolution of amniotic fluid volume. In polyhydramnios, AQP-3 level tended to be decreased whereas AQP-8 level was decreased from mid-gestation whatever the etiology of polyhydramnios. No significant relationship was found between AQPs levels and either the fetal prematurity degree or macrosomia. No specific pattern was observed in idiopathic polyhydramnios, limiting the interest of AQPs dosage in amniotic fluid in the management of those complicated pregnancies.

Identifiants

pubmed: 34254277
doi: 10.1007/s43032-021-00677-1
pii: 10.1007/s43032-021-00677-1
doi:

Substances chimiques

Aquaporins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2929-2938

Informations de copyright

© 2021. Society for Reproductive Investigation.

Références

Larsen W. Fetal development and the fetus as a patient. In : essentials of human embryology. Churchill Livingstone, New York, 1998.
Liu H, Zheng Z, Wintour EM. Aquaporins and fetal fluid balance. Placenta. 2008;29:840–7.
doi: 10.1016/j.placenta.2008.07.010
Underwood M, Gilbert W, Sherman M. Amniotic fluid: not just fetal urine anymore. J Perinatol. 2005;25:341–8.
doi: 10.1038/sj.jp.7211290
Beall M, van den Wijngaard J, van Gemert M, Ross M. Regulation of amniotic fluid volume. Placenta. 2007;28:824–32.
doi: 10.1016/j.placenta.2006.12.004
Burc L, Guibourdenche J, Luton D, Noël M, Beaudeux JL, De Lagausie P, et al. Establishment of reference values of five enzymes in amniotic fluid. Analytical performances of Hitachi 911. Application to complicated pregnancies. Clin Biochem. 2001;34:317–22.
doi: 10.1016/S0009-9120(01)00228-4
Allaf B, Dreux S, Schmitz T, Czerkiewicz I, Le Vaillant C, Benachi A, et al. Amniotic fluid biochemistry in isolated polyhydramnios: a serie of 464 cases. Prenat Diagn. 2015;35:1331–5.
doi: 10.1002/pd.4700
Denker B, Smith B, Kuhajda F, Agre P. Identification, purification, and partial characterization of a novel Mr 28,000 integral membrane protein from erythrocytes and renal tubules. J Biol Chem. 1988;263:15634–42.
doi: 10.1016/S0021-9258(19)37635-5
Kordowitzki P, Kranc W, Bryl R, Kempisty B, Skowronska A, Skowronski M. The relevance of aquaporins for the physiology, pathology, and aging of the female reproductive system in mammals. Cells. 2020;9:2570. https://doi.org/10.3390/cells9122570 .
doi: 10.3390/cells9122570 pmcid: 7760214
Azad A, Raihan T, Ahmaed J, Hakim A, Emon T, Chowdhury P. Human aquaporins: functional diversity and potential roles in infectious and non infectious diseases. Front Genet. 12:654865. https://doi.org/10.3389/fgene.2021.654865 .
Liu H, Wintour EM. Aquaporins in development-a review. Reprod Biol Endocrinol. 2005;3:1–10.
doi: 10.1186/1477-7827-3-1
Kwon T, Hager H, Nejsum L, Andersen M, Frokiaer J, Nielsen S. Physiology and pathophysiology of renal aquaporins. Semin Nephrol. 2001;21:231–8.
doi: 10.1053/snep.2001.21647
Rai T, Sekine K, Kanno K, et al. Urinary excretion of aquaporin-2 water channel protein in human and rat. J Am Soc Nephrol. 1997;8:1357–62.
doi: 10.1681/ASN.V891357
Feng J, Chen Y, Yan S, Wen L, Guo X, Wen Y. The relationship between Aquaporin-2 protein levels in amniotic fluid and the fetal kidney in humans. Biochem Biophys Research Comm. 2018;506:585–9.
doi: 10.1016/j.bbrc.2018.10.097
Wang S, Kallichanda N, Song W, Ramirez B, Ross M. Expression of aquaporin-8 in human placenta and chorioamniotic membranes: evidence of molecular mechanism for intramembranous amniotic fluid resorption. Am J Obstet Gynecol. 2001;185:1226–31.
doi: 10.1067/mob.2001.117971
Damiano A, Zotta E, Goldstein J, Reisin I, Ibarra C. Water chanel proteins AQP3 and AQP9 are present in syncytiotrophoblast of human term placenta. Placenta. 2001;22:776–81.
doi: 10.1053/plac.2001.0717
Mann S, Ricke E. yang B, Verkman A, Taylor R. Expression and localization of aquaporine 1 and 3 in human fetal membranes. Am J Obstet Gynecol. 2002;187:902–7.
doi: 10.1067/mob.2002.127168
Damiano AE. Review: water channel proteins in the human placenta and fetal membranes. Placenta. 2011;32(25):S207–11. https://doi.org/10.1016/j.placenta.2010.12.012 .
doi: 10.1016/j.placenta.2010.12.012 pubmed: 21208655
Prat C, Blanchon L, Borel V, et al. Ontogeny of aquaporins in human fetal membranes. Biol Reprod. 2012;86:1–8.
doi: 10.1095/biolreprod.111.095448
Mann S, Dvorak N, Gilbert H, Taylor R. Steady-state levels of aquaporin 1 mRNA expression are increased in idiopathic polyhydramnios. Am J Obstet Gynecol. 2006;194:884–7.
doi: 10.1016/j.ajog.2005.07.004
Zhu X, Jiang S, Zou S, Wang Y, Hu Y. Expression of aquaporin 1 and aquaporin 3 in fetal membranes and placenta in human term pregnancies with oligohydramnios. Placenta. 2009;30:670–6.
doi: 10.1016/j.placenta.2009.05.010
Wladimiroff J, Eik-Nes S. Amniotic fluid and placental localization. In: Wladimiroff J, Eik-Nes S, editors. Ultrasound in obstetrics and gynaecology: Elsevier; 2009. chapter 6. p. 109–32.
Chamberlain P, Mannning F, Morrison I, Harman C, Lange I. Ultrasound evaluation of amniotic fluid volume. I. The relationship of increased amniotic fluid volume to perinatal outcome. Am J Obstet Gynecol. 1984;150:250–4.
doi: 10.1016/S0002-9378(84)90360-0
Phelan JP, Smith CV, Broussard P, Small M. Amniotic fluid volume assessment with the four-quadrant technique at 36-42 weeks' gestation. J Reprod Med. 1987;32:540–2.
pubmed: 3305930
Burc L, Voluménie JL, De Lagausie P, Guibourdenche J, Oury JF, Vuillard E, et al. Amniotic fluid inflammatory proteins and digestive compounds profile fetuses with gastroschisis undergoing amnioexchange. BJOG. 2004;111:292–7.
doi: 10.1111/j.1471-0528.2004.00070.x
Leguy MC, Dos Reis Tavares S, Vassilis T, Lewin F, Clauser E, Guibourdenche J. Establishment of normative values for AFP in amniotic fluid using the Advia Centaur XP: comparison of three automates. An Biol Clin. 2011;69:441–6.
Ducza E, Csanyi A, Gaspar R. Aquaporins during pregnancy: their function and significance. Int J Mol Sci. 2017;18:2593. https://doi.org/10.3390/ijms18122593 .
doi: 10.3390/ijms18122593 pmcid: 5751196
Fujino Y, Agnew C, Schreyer P, Ervin M, Sherman D. M Ross. Amniotic fluid volume response to oesophageal occlusion in fetal sheep. Am J Obstet Gynecol. 1991;165:1620–6.
doi: 10.1016/0002-9378(91)90005-C
Anderson D, Jonker S, Loucy C, Cheung Y, Brace R. Regulation of intramembranous absorption and amniotic fluid volume by constituents in fetal sheep urine. Am J Phys Regul Integr Comp Phys. 2013;305:R506–11.
Brace E, Cheung C, Anderson D. Regulation of amniotic fluid volume: insights derived from amniotic fluid volume function curves. Am J Phys Regul Integr Comp Phys. 2018;315:R777–89.
Machado M, Cecatti J, Krupa F, Faundes A. Curve of amniotic fluid index measurements in low-risk pregnancy. Acta Obstet Gynecol Scand. 2007;86:37–41.
doi: 10.1080/00016340600994976
Liu H, Koukoulas I, Ross M, Wang S, Wintour EM. Quantitative comparison of placental expression of three aquaporin genes. Placenta. 2004;25:475–8.
doi: 10.1016/j.placenta.2003.10.008
Johnston H, Koukoulas I, Jeyaseelan K, et al. Ontogeny of aquaporins 1 and 3 in ovine placenta and fetal membranes. Placenta. 2000;21:88–99.
doi: 10.1053/plac.1999.0445
Kobayashi K, Yasui M. Cellular and subcellular localization of aquaporins 1, 3, 8 and 9 in amniotic membranes during pregnancy in mice. Cell Tissue Res. 2010;342:307–16.
doi: 10.1007/s00441-010-1065-6
Beall MH, Wang S, Yang B, Chaudhri N, Amidi F, Ross MG. Placental and membrane aquaporin water channels: correlation with amniotic fluid volume and composition. Placenta. 2007;28:421–8.
doi: 10.1016/j.placenta.2006.06.005
Mann S, Ricke E, Torres E, Taylor R. A novel model of polyhydramnios: amniotic fluid volume is increased in aquaporin 1 knockout mice. Am J Obstet Gynecol. 2005;192:2041–6.
doi: 10.1016/j.ajog.2005.02.046
Bouvier D, Rouzaire L, Marceau G, Prat C, Pereira B, Lemarié R, et al. Aquaporins and fetal membranes from diabetic parturient women: expression, abnormalities and regulation by insulin. J Clin Endocrinol Metab. 2015;100:E1270–9.
doi: 10.1210/jc.2015-2057
Bednar A, Beardall M, Brace R, Cheung C. Differencial expression and regional distribution of aquaporins in amnion of normal and gestational diabetic pregnancies. Phys Rep. 2015;3:e12320. https://doi.org/10.14814/phy2.12320 .
doi: 10.14814/phy2.12320
Matsumoto L, Cheung C, Brace R, Cheung C. Effect of esophageal ligation on amniotic fluid volume and urinary flow rate in fetal sheep. Am J Obstet Gynecol. 2000;182:699–705.
doi: 10.1067/mob.2000.104226
Ishikawa S, Schrier R. Pathophysiological roles of arginine vasopressin and aquaporin-2 in impaired water excretion. Clin Endocrinol. 2003;58:1–17.
doi: 10.1046/j.1365-2265.2003.01647.x
Magann E, Chauhan S, Doherty D, Lutgendorf M, Magann M, Morrison J. A review of idiopathic hydramnios and pregnancy outcomes. Obstet Gynecol Surv. 2007;62:795–802.
doi: 10.1097/01.ogx.0000290349.58707.e0

Auteurs

Jean Guibourdenche (J)

Departement of Hormonology GH APHP Centre, Hormonologie, CHU Hopital Cochin, 27 rue du Fg St Jacques, 75014, Paris, France. jean.guibourdenche@aphp.fr.
Université de Paris, Paris, France. jean.guibourdenche@aphp.fr.
FHU PREMA, Paris, France. jean.guibourdenche@aphp.fr.

Fideline Bonnet-Serrano (F)

Departement of Hormonology GH APHP Centre, Hormonologie, CHU Hopital Cochin, 27 rue du Fg St Jacques, 75014, Paris, France.
Université de Paris, Paris, France.

Lila Younes Chaouch (L)

FHU PREMA, Paris, France.
Departement of Gynecology and Obstetrics, GH APHP Centre, Hopital Cochin, Paris, France.

Vincent Sapin (V)

Departement of Biochemistry and Molecular Genetics, CHU Clermont, Clermont Ferrand, France.

Vassilis Tsatsaris (V)

Université de Paris, Paris, France.
FHU PREMA, Paris, France.
Departement of Gynecology and Obstetrics, GH APHP Centre, Hopital Cochin, Paris, France.

David Combarel (D)

Departement of Hormonology GH APHP Centre, Hormonologie, CHU Hopital Cochin, 27 rue du Fg St Jacques, 75014, Paris, France.

Christelle Laguillier (C)

Departement of Hormonology GH APHP Centre, Hormonologie, CHU Hopital Cochin, 27 rue du Fg St Jacques, 75014, Paris, France.
Université de Paris, Paris, France.
FHU PREMA, Paris, France.

Gilles Grange (G)

FHU PREMA, Paris, France.
Departement of Gynecology and Obstetrics, GH APHP Centre, Hopital Cochin, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH